Glycosylation-mediated targeting of carriers

Journal of Controlled Release

Volumn 190, Issue , 2014, Pages 542-555

  Kawakami, Shigeru ^a   Hashida, Mitsuru ^b,c  

^a NAGASAKI UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c KYOTO UNIVERSITY   (Japan)

Author keywords

Drug delivery; Glycosylation; Liposomes; Macromolecular carriers; Targeting

Indexed keywords

CONTROLLED DRUG DELIVERY; DRUG DELIVERY; GLYCOSYLATION; LIGANDS; LIPOSOMES; MACROMOLECULES; MOLECULAR BIOLOGY;

DISTRIBUTION PROFILES; DRUG DELIVERY SYSTEM; LIGAND-RECEPTOR BINDING; RECEPTOR-MEDIATED ENDOCYTOSIS; SPECIFIC RECOGNITION; TARGETED DRUG DELIVERY SYSTEMS; TARGETING; THERAPEUTIC EFFICACY;

TARGETED DRUG DELIVERY;

4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; COMPLEMENTARY DNA; DOXORUBICIN; DRUG CARRIER; FUCOSE; GALACTOSE; GENOMIC DNA; GLIOTOXIN; LIGAND; LIPOSOME; LOSARTAN; MANNOSE; MANNOSE 6 PHOSPHATE; NUCLEIC ACID; OLIGONUCLEOTIDE; PLASMID DNA; PROSTAGLANDIN E1; VIDARABINE PHOSPHATE; MACROMOLECULE; NANOPARTICLE;

ARTICLE; BINDING AFFINITY; CHEMICAL MODIFICATION; DENDRITIC CELL; DRUG CLEARANCE; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG TARGETING; ENDOCYTOSIS; GLYCOSYLATION; HUMAN; LIPOSOMAL DELIVERY; LIVER CELL; MACROMOLECULE; MOLECULAR RECOGNITION; MOLECULARLY TARGETED THERAPY; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; RECEPTOR BINDING; STELLATE CELL; ULTRASOUND; ADMINISTRATION AND DOSAGE; CHEMISTRY; PHARMACOKINETICS;

DRUG CARRIERS; DRUG DELIVERY SYSTEMS; ENDOCYTOSIS; GLYCOSYLATION; HUMANS; LIPOSOMES; MACROMOLECULAR SUBSTANCES; NANOPARTICLES;

EID: 84906784450     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2014.06.001     Document Type: Review

References (239)

1. H. Sezaki, and M. Hashida Macromolecule-drug conjugates in targeted cancer chemotherapy Crit. Rev. Ther. Drug Carrier Syst. 1 1984 1 38 (Pubitemid 15062288)
2. Y. Takakura, and M. Hashida Macromolecular carrier systems for targeted drug delivery: pharmacokinetic considerations on biodistribution Pharm. Res. 13 1996 820 831 (Pubitemid 26227738)
3. S. Kawakami, F. Yamashita, K. Nishida, J. Nakamura, and M. Hashida Glycosylated cationic liposomes for cell-selective gene delivery Crit. Rev. Drug Carrier Syst. 19 2002 171 190
4. R.P. Harbottle, R.G. Cooper, S.L. Hart, A. Ladhoff, T. McKay, A.M. Knight, E. Wagner, A.D. Miller, and C. Coutelle An RGD-oligolysine peptide: a prototype construct for integrin-mediated gene delivery Hum. Gene Ther. 9 1998 1037 1047 (Pubitemid 28236512)
5. E. Kenjo, T. Asai, N. Yonenaga, H. Ando, T. Ishii, K. Hatanaka, K. Shimizu, Y. Urita, T. Dewa, M. Nango, H. Tsukada, and N. Oku Systemic delivery of small interfering RNA by use of targeted polycation liposomes for cancer therapy Biol. Pharm. Bull. 36 2012 287 291
6. M. Vidal, J. Sainte-Marie, J.R. Philippot, and A. Bienvenue The influence of coupling transferrin to liposomes or minibeads on its uptake and fate in leukemic L2C cells FEBS Lett. 216 1987 159 163 (Pubitemid 17089047)
7. O. Ishida, K. Maruyama, H. Tanahashi, M. Iwatsuru, K. Sasaki, M. Eriguchi, and H. Yanagie Liposomes bearing polyethyleneglycol-coupled transferrin with intracellular targeting property to the solid tumors in vivo Pharm. Res. 18 2001 1042 1048 (Pubitemid 32799953)
8. A. Kikuchi, S. Sugaya, H. Ueda, K. Tanaka, Y. Aramaki, T. Hara, H. Arima, S. Tsuchiya, and T. Fuwa Efficient gene transfer to EGF receptor overexpressing cancer cells by means of EGF-labeled cationic liposomes Biochem. Biophys. Res. Commun. 227 1996 666 671 (Pubitemid 26387785)
9. D. Kirpotin, J.W. Park, K. Hong, S. Zalipsky, W.L. Li, P. Carter, C.C. Benz, and D. Papahadjopoulos Sterically stabilized anti-HER2 immunoliposomes: design and targeting to human breast cancer cells in vitro Biochemistry 36 1997 66 75 (Pubitemid 27024679)
10. T. Miyano, W. Wijagkanalan, S. Kawakami, F. Yamashita, and M. Hashida Anionic amino acid dendrimer-trastuzumab conjugates for specific internalization in HER2-positive cancer cells Mol. Pharm. 7 2010 1318 1327
11. C. Scholz, and E. Wagner Therapeutic plasmid DNA versus siRNA delivery: Common and different tasks for synthetic carriers J Control Release 161 2012 554 565
12. R. Kole, A.R. Krainer, and S. Altman RNA therapeutics: beyond RNA interference and antisense oligonucleotides Nat. Rev. Drug Discov. 11 2012 125 140
13. S.T. Crooke, and R.S. Geary Clinical pharmacological properties of mipomersen (Kynamro), a second generation antisense inhibitor of apolipoprotein B Br. J. Clin. Pharmacol. 76 2013 269 276
14. Y. Zhang, Z. Wang, and R.A. Gemeinhart Progress in microRNA delivery J. Control. Release 172 2013 962 974
15. M. Kullberg, R. McCarthy, and T.J. Anchordoquy Systemic tumor-specific gene delivery J. Control. Release 172 2013 730 736
16. M. Yamada, M. Nishikawa, S. Kawakami, Y. Hattori, T. Nakano, F. Yamashita, and M. Hashida Tissue and intrahepatic distribution and subcellular localization of a mannosylated lipoplex after intravenous administration in mice J. Control. Release 98 2004 157 167 (Pubitemid 38881615)
17. I.A. Khalil, K. Kogure, H. Akita, and H. Harashima Uptake pathways and subsequent intracellular trafficking in nonviral gene delivery Pharmacol. Rev. 58 2006 32 45
18. Y. Takakura, R.I. Mahato, and M. Hashida Extravasation of macromolecules Adv. Drug Deliv. Rev. 34 1998 93 108 (Pubitemid 28464480)
19. F. Yamashita, and M. Hashida Pharmacokinetic considerations for targeted drug delivery Adv. Drug Deliv. Rev. 65 2013 139 147
20. K. Mihara, M. Mori, T. Hojo, Y. Takakura, H. Sezaki, and M. Hashida Disposition characteristics of model macromolecules in the perfused rat kidney Biol. Pharm. Bull. 16 1993 158 162 (Pubitemid 23129191)
21. K. Nishida, K. Mihara, T. Takino, S. Nakane, Y. Takakura, M. Hashida, and H. Sezaki Hepatic disposition characteristics of electrically charged macromolecules in rat in vivo and in the perfused liver Pharm. Res. 8 1991 437 444
22. S.F. Ma, M. Nishikawa, H. Katsumi, F. Yamashita, and M. Hashida Cationic charge-dependent hepatic delivery of amidated serum albumin J. Control. Release 102 2005 583 594 (Pubitemid 40170202)
23. K. Kawabata, Y. Takakura, and M. Hashida The fate of plasmid DNA after intravenous injection in mice: involvement of scavenger receptors in its hepatic uptake Pharm. Res. 12 1995 825 830
24. Y. Yamasaki, K. Sumimoto, M. Nishikawa, F. Yamashita, K. Yamaoka, M. Hashida, and Y. Takakura Pharmacokinetic analysis of in vivo disposition of succinylated proteins targeted to liver nonparenchymal cells via scavenger receptors: importance of molecular size and negative charge density for in vivo recognition by receptors J. Pharmacol. Exp. Ther. 301 2002 467 477 (Pubitemid 34429956)
25. Y. Yamasaki, J. Hisazumi, K. Yamaoka, and Y. Takakura Efficient scavenger receptor-mediated hepatic targeting of proteins by introduction of negative charges on the proteins by aconitylation: the influence of charge density and size of the proteins molecules Eur. J. Pharm. Sci. 18 2003 305 312 (Pubitemid 36407690)
26. E. Wisse An electron microscopic study of the fenestrated endothelial lining of rat liver sinusoids J. Ultrastruct. Res. 31 1970 125 150
27. T. Daemen, M. Velinova, J. Regts, M. de Jager, R. Kalicharan, J. Donga, J.J. van der Want, and G.L. Scherphof Different intrahepatic distribution of phosphatidylglycerol and phosphatidylserine liposomes in the rat Hepatology 26 1997 416 423 (Pubitemid 27328320)
28. M. Nishikawa, A. Kamijo, T. Fujita, Y. Takakura, H. Sezaki, and M. Hashida Synthesis and pharmacokinetics of a new liver-specific carrier, glycosylated carboxymethyl-dextran, and its application to drug targeting Pharm. Res. 10 1993 1253 1261 (Pubitemid 23261822)
29. L. Fiume, B. Bassi, C. Busi, A. Mattioli, G. Spinosa, and H. Faulstich Galactosylated poly(L-lysine) as a hepatotropic carrier of 9-β-D- arabinofuranosyladenine 5′-monophosphate FEBS Lett. 203 1986 203 206 (Pubitemid 16046799)
30. G.Y. Wu, and C.H. Wu Receptor-mediated gene delivery and expression in vivo J. Biol. Chem. 263 1988 14621 14624
31. M. Hashida, S. Takemura, M. Nishikawa, and Y. Takakura Targeted delivery of plasmid DNA complexed with galactosylated poly(L-lysine) J. Control. Release 53 1998 301 310 (Pubitemid 28218713)
32. M. Nishikawa, S. Takemura, Y. Takakura, and M. Hashida Targeted delivery of plasmid DNA to hepatocytes in vivo: optimization of the pharmacokinetics of plasmid DNA/galactosylated poly(L-lysine) complexes by controlling their physicochemical properties J. Pharmacol. Exp. Ther. 287 1998 408 415 (Pubitemid 29140227)
33. S.J. Zheng, S. Zhong, J.J. Zhang, F. Chen, H. Ren, and C.L. Deng Distribution and anti-HBV effects of antisense oligodeoxynucleotides conjugated to galactosylated poly-L-lysine World J. Gastroenterol. 9 2003 1251 1255 (Pubitemid 36805662)
34. H. Hirabayashi, M. Nishikawa, Y. Takakura, and M. Hashida Development and pharmacokinetics of galactosylated poly-L-glutamic acid as a biodegradable carrier for liver-specific drug delivery Pharm. Res. 13 1996 880 884 (Pubitemid 26227745)
35. 1 polymeric prodrug and its potential for preventing carbon tetrachloride-induced fulminant hepatitis in mice J. Pharmacol. Exp. Ther. 290 1999 1242 1249 (Pubitemid 29400266)
36. 1 having galactose residue for hepatocyte targeting J. Control. Release 62 1999 253 262 (Pubitemid 29486505)
37. M.A. Zanta, O. Boussif, A. Adib, and J.P. Behr In vitro gene delivery to hepatocytes with galactosylated polyethylenimine Bioconjug. Chem. 8 1997 839 844 (Pubitemid 27526411)
38. T. Bettinger, J.S. Remy, and P. Erbacher Size reduction of galactosylated PEI/DNA complexes improves lectin-mediated gene transfer into hepatocytes Bioconjug. Chem. 10 1999 558 561 (Pubitemid 29355232)
39. K. Sagara, and S.W. Kim A new synthesis of galactose-poly(ethylene glycol)-polyethylenimine for gene delivery to hepatocytes J. Control. Release 79 2002 271 281 (Pubitemid 34164179)
40. K. Morimoto, M. Nishikawa, S. Kawakami, T. Nakano, Y. Hattori, S. Fumoto, F. Yamashita, and M. Hashida Molecular weight-dependent gene transfection activity of unmodified and galactosylated polyethyleneimine on hepatoma cells and mouse liver Mol. Ther. 7 2003 254 261 (Pubitemid 36395361)
41. S. Fumoto, S. Kawakami, M. Ishizuka, M. Nishikawa, F. Yamashita, and M. Hashida Analysis of hepatic disposition of unmodified and galactosylated polyethylenimine complexed with plasmid DNA in the rat perfused liver Drug Metab. Pharmacokinet. 18 2003 230 237
42. K. Ma, H. Shen, S. Shen, M. Xie, C. Mao, L. Qiu, and Y. Jin Development of a successive targeting liposome with multi-ligand for efficient targeting gene delivery J. Gene Med. 13 2011 290 301
43. I.K. Park, Y.H. Park, B.A. Shin, E.S. Choi, Y.R. Kim, T. Akaike, and C.S. Cho Galactosylated chitosan-graft-dextran as hepatocyte-targeting DNA carrier J. Control. Release 69 2000 97 108
44. I.K. Park, T.H. Kim, Y.H. Park, B.A. Shin, E.S. Choi, E.H. Chowdhury, T. Akaike, and C.S. Cho Galactosylated chitosan-graft-poly(ethylene glycol) as hepatocyte-targeting DNA carrier J. Control. Release 76 2001 349 362 (Pubitemid 32913442)
45. S. Gao, J. Chen, X. Xu, Z. Ding, Y.H. Yang, Z. Hua, and J. Zhang Galactosylated low molecular weight chitosan as DNA carrier for hepatocyte-targeting Int. J. Pharm. 255 2003 57 68 (Pubitemid 36369591)
46. T.H. Kim, I.K. Park, J.W. Nah, Y.J. Choi, and C.S. Cho Galactosylated chitosan/DNA nanoparticles prepared using water-soluble chitosan as a gene carrier Biomaterials 25 2004 3783 3792 (Pubitemid 38327067)
47. M. Cheng, Q. Li, T. Wan, X. Hong, H. Chen, B. He, Z. Cheng, H. Xu, T. Ye, B. Zha, J. Wu, and R. Zhou Synthesis and efficient hepatocyte targeting of galactosylated chitosan as a gene carrier in vitro and in vivo J. Biomed. Mater. Res. B Appl. Biomater. 99 2011 70 80
48. K. Wada, H. Arima, T. Tsutsumi, F. Hirayama, and K. Uekama Enhancing effects of galactosylated dendrimer/α-cyclodextrin conjugates on gene transfer efficiency Biol. Pharm. Bull. 28 2005 500 505 (Pubitemid 40879976)
49. B. Lu, D.Q. Wu, H. Zheng, C.Y. Quan, X.Z. Zhang, and R.X. Zhuo Galactosyl conjugated N-succinyl-chitosan-graft-polyethylenimine for targeting gene transfer Mol. Biosyst. 6 2010 2529 2538
50. J.H. Kim, Y.K. Kim, M.T. Arash, S.H. Hong, J.H. Lee, B.N. Kang, Y.B. Bang, C.S. Cho, D.Y. Yu, H.L. Jiang, and M.H. Cho Galactosylation of chitosan-graft-spermine as a gene carrier for hepatocyte targeting in vitro and in vivo J. Nanosci. Nanotechnol. 12 2012 5178 51784
51. K. Akamatsu, M. Imai, Y. Yamasaki, M. Nishikawa, Y. Takakura, and M. Hashida Disposition characteristics of glycosylated poly(amino acids) as liver cell-specific drug carrier J. Drug Target. 6 1998 229 239 (Pubitemid 29034291)
52. M. Nishikawa, C. Miyazaki, F. Yamashita, Y. Takakura, and M. Hashida Galactosylated proteins are recognized by the liver according to the surface density of galactose moieties Am. J. Physiol. 268 1995 G849 G856
53. O. Boussif, F. Lezoualc'h, M.A. Zanta, M.D. Mergny, D. Scherman, B. Demeneix, and J.P. Behr A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine Proc. Natl. Acad. Sci. U. S. A. 92 1995 7297 7301
54. M. Nishikawa, M. Yamauchi, K. Morimoto, E. Ishida, Y. Takakura, and M. Hashida Hepatocyte-targeted in vivo gene expression by intravenous injection of plasmid DNA complexed with synthetic multi-functional gene delivery system Gene Ther. 7 2000 548 555 (Pubitemid 30175557)
55. T.H. Kim, S.I. Kim, T. Akaike, and C.S. Cho Synergistic effect of poly(ethylenimine) on the transfection efficiency of galactosylated chitosan/DNA complexes J. Control. Release 105 2005 354 366 (Pubitemid 40941999)
56. M. Hohokabe, Y. Higuchi, H. Mukai, S. Kawakami, and M. Hashida Hepatocyte-selective gene transfer by galactosylated protein/linear polyethyleneimine/plasmid DNA complexes in mice J. Biomed. Nanotechnol. 3 2007 277 284 (Pubitemid 351877154)
57. J.C. Robbins, M.H. Lam, C.S. Tripp, R.L. Bugianesi, M.M. Ponpipom, and T.Y. Shen Synthetic glycopeptide substrates for receptor-mediated endocytosis by macrophages Proc. Natl. Acad. Sci. U. S. A. 78 1981 7294 7298 (Pubitemid 12186126)
58. C. Tietze, P. Schlesinger, and P. Stahl Mannose-specific endocytosis receptor of alveolar macrophages: demonstration of two functionally distinct intracellular pools of receptor and their roles in receptor recycling J. Cell Biol. 92 1982 417 424 (Pubitemid 12157414)
59. S.A. Weston, and C.R. Parish Evidence that mannose recognition by splenic sinusoidal cells plays a role in the splenic entry of lymphocytes Eur. J. Immunol. 22 1992 1975 1981
60. F. Sallusto, M. Cella, C. Danieli, and A. Lanzavecchia Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products J. Exp. Med. 182 1995 389 400
61. W. Wijagkanalan, S. Kawakami, and M. Hashida Glycosylated carriers for cell-selective and nuclear delivery of nucleic acids Front. Biosci. 16 2011 2970 2987
62. P. Erbacher, M.T. Bousser, J. Raimond, M. Monsigny, P. Midoux, and A.C. Roche Gene transfer by DNA/glycosylated polylysine complexes into human blood monocyte-derived macrophages Hum. Gene Ther. 7 1996 721 729 (Pubitemid 26125842)
63. R.I. Mahato, S. Takemura, K. Akamatsu, M. Nishikawa, Y. Takakura, and M. Hashida Physicochemical and disposition characteristics of antisense oligonucleotides complexed with glycosylated poly(L-lysine) Biochem. Pharmacol. 53 1997 887 895 (Pubitemid 27145791)
64. M. Nishikawa, S. Takemura, F. Yamashita, Y. Takakura, D.K. Meijer, M. Hashida, and P.J. Swart Pharmacokinetics and in vivo gene transfer of plasmid DNA complexed with mannosylated poly(L-lysine) in mice J. Drug Target. 8 2000 29 38 (Pubitemid 30189691)
65. N. Brandhonneur, F. Chevanne, V. Vié, B. Frisch, R. Primault, M.F. Le Potier, and P. Le Corre Specific and non-specific phagocytosis of ligand-grafted PLGA microspheres by macrophages Eur. J. Pharm. Sci. 36 2009 474 485
66. S.S. Diebold, H. Lehrmann, M. Kursa, E. Wagner, M. Cotten, and M. Zenke Efficient gene delivery into human dendritic cells by adenovirus polyethylenimine and mannose polyethylenimine transfection Hum. Gene Ther. 10 1999 775 786 (Pubitemid 29168162)
67. S.S. Diebold, M. Kursa, E. Wagner, M. Cotten, and M. Zenke Mannose polyethylenimine conjugates for targeted DNA delivery into dendritic cells J. Biol. Chem. 274 1999 19087 19094
68. I.Y. Park, I.Y. Kim, M.K. Yoo, Y.J. Choi, and M.H. Cho CS. Cho, Mannosylated polyethylenimine coupled mesoporous silica nanoparticles for receptor-mediated gene delivery Int. J. Pharm. 359 2008 280 287
69. N. Kim, D. Jiang, A.M. Jacobi, K.A. Lennox, S.D. Rose, M.A. Behlke, and A.K. Salem Synthesis and characterization of mannosylated pegylated polyethylenimine as a carrier for siRNA Int. J. Pharm. 427 2012 123 133
70. X. Sun, S. Chen, J. Han, and Z. Zhang Mannosylated biodegradable polyethyleneimine for targeted DNA delivery to dendritic cells Int. J. Nanomedicine 7 2012 2929 2942
71. M. Hashimoto, M. Morimoto, H. Saimoto, Y. Shigemasa, H. Yanagie, M. Eriguchi, and T. Sato Gene transfer by DNA/mannosylated chitosan complexes into mouse peritoneal macrophages Biotechnol. Lett. 28 2006 815 821 (Pubitemid 43926904)
72. T.H. Kim, H. Jin, H.W. Kim, M.H. Cho, and C.S. Cho Mannosylated chitosan nanoparticle-based cytokine gene therapy suppressed cancer growth in BALB/c mice bearing CT-26 carcinoma cells Mol. Cancer Ther. 5 2006 1723 1732 (Pubitemid 44323240)
73. W. Yao, Y. Peng, M. Du, J. Luo, and L. Zong Preventative vaccine-loaded mannosylated chitosan nanoparticles intended for nasal mucosal delivery enhance immune responses and potent tumor immunity Mol. Pharm. 10 2013 2904 2914
74. K. Wada, H. Arima, T. Tsutsumi, Y. Chihara, K. Hattori, F. Hirayama, and K. Uekama Improvement of gene delivery mediated by mannosylated dendrimer/α-cyclodextrin conjugates J. Control. Release 104 2005 397 413 (Pubitemid 40724937)
75. H. Arima, Y. Chihara, M. Arizono, S. Yamashita, K. Wada, F. Hirayama, and K. Uekama Enhancement of gene transfer activity mediated by mannosylated dendrimer/α -cyclodextrin conjugate (generation 3, G3) J. Control. Release 116 2006 64 74 (Pubitemid 44792299)
76. P. Opanasopit, K. Shirashi, M. Nishikawa, F. Yamashita, Y. Takakura, and M. Hashida In vivo recognition of mannosylated proteins by hepatic mannose receptors and mannan-binding protein Am. J. Physiol. Gastrointest. Liver Physiol. 280 2001 G879 G889
77. P. Ghosh, N.M. Dahms, and S. Kornfeld Mannose 6-phosphate receptors: new twists in the tale Nat. Rev. Mol. Cell Biol. 4 2003 202 212 (Pubitemid 36288042)
78. P. Lemansky, I. Fester, E. Smolenova, C. Uhländer, and A. Hasilik The cation-independent mannose 6-phosphate receptor is involved in lysosomal delivery of serglycin J. Leukoc. Biol. 81 2007 1149 1158 (Pubitemid 46495664)
79. I. Martin-Kleiner, and K.G. Troselj Mannose-6-phosphate/insulin-like growth factor 2 receptor (M6P/IGF2R) in carcinogenesis Cancer Lett. 289 2010 11 22
80. 4-exposed rat fat-storing cells and facilitates activation of latent transforming growth factor-β in cocultures with sinusoidal endothelial cells Hepatology 21 1995 1429 1437
81. 4 intoxication in the rat Hepatology 23 1996 1530 1537 (Pubitemid 26181237)
82. J.A. Weiner, A. Chen, and B.H. Davis E-box-binding repressor is down-regulated in hepatic stellate cells during up-regulation of mannose 6-phosphate/insulin-like growth factor-II receptor expression in early hepatic fibrogenesis J. Biol. Chem. 273 1998 15913 15919 (Pubitemid 28311354)
83. A. Geerts History, heterogeneity, developmental biology, and functions of quiescent hepatic stellate cells Semin. Liver Dis. 21 2001 311 335 (Pubitemid 32923763)
84. L. Beljaars, G. Molema, B. Weert, H. Bonnema, P. Olinga, G.M. Groothuis, D.K. Meijer, and K. Poelstra Albumin modified with mannose 6-phosphate: A potential carrier for selective delivery of antifibrotic drugs to rat and human hepatic stellate cells Hepatology 29 1999 1486 1493 (Pubitemid 29211051)
85. 28-HSA) Liver 21 2001 320 328 (Pubitemid 32910556)
86. R. Greupink, H.I. Bakker, W. Bouma, C. Reker-Smit, D.K. Meijer, L. Beljaars, and K. Poelstra The antiproliferative drug doxorubicin inhibits liver fibrosis in bile duct-ligated rats and can be selectively delivered to hepatic stellate cells in vivo J. Pharmacol. Exp. Ther. 317 2006 514 521
87. W.I. Hagens, L. Beljaars, D.A. Mann, M.C. Wright, B. Julien, S. Lotersztajn, C. Reker-Smit, and K. Poelstra Cellular targeting of the apoptosis-inducing compound gliotoxin to fibrotic rat livers J. Pharmacol. Exp. Ther. 324 2008 902 910 (Pubitemid 351397843)
88. T. Gonzalo, L. Beljaars, M. van de Bovenkamp, K. Temming, A.M. van Loenen, C. Reker-Smit, D.K. Meijer, M. Lacombe, F. Opdam, G. Kéri, L. Orfi, K. Poelstra, and R.J. Kok Local inhibition of liver fibrosis by specific delivery of a platelet-derived growth factor kinase inhibitor to hepatic stellate cells J. Pharmacol. Exp. Ther. 321 2007 856 865 (Pubitemid 46762697)
89. M. Moreno, T. Gonzalo, R.J. Kok, P. Sancho-Bru, M. van Beuge, J. Swart, J. Prakash, K. Temming, C. Fondevila, L. Beljaars, M. Lacombe, P. van der Hoeven, V. Arroyo, K. Poelstra, D.A. Brenner, P. Ginès, and R. Bataller Reduction of advanced liver fibrosis by short-term targeted delivery of an angiotensin receptor blocker to hepatic stellate cells in rats Hepatology 51 2010 942 952
90. M.M. van Beuge, J. Prakash, M. Lacombe, E. Post, C. Reker-Smit, L. Beljaars, and K. Poelstra Increased liver uptake and reduced hepatic stellate cell activation with a cell-specific conjugate of the Rho-kinase inhibitor Y27632 Pharm. Res. 28 2011 2045 2054
91. M.M. van Beuge, J. Prakash, M. Lacombe, R. Gosens, E. Post, C. Reker-Smit, L. Beljaars, and K. Poelstra Reduction of fibrogenesis by selective delivery of a Rho kinase inhibitor to hepatic stellate cells in mice J. Pharmacol. Exp. Ther. 337 2011 628 635
92. S. Klein, M.M. Van Beuge, M. Granzow, L. Beljaars, R. Schierwagen, S. Kilic, I. Heidari, S. Huss, T. Sauerbruch, K. Poelstra, and J. Trebicka HSC-specific inhibition of Rho-kinase reduces portal pressure in cirrhotic rats without major systemic effects J. Hepatol. 57 2012 1220 1227
93. M.M. van Beuge, J. Prakash, M. Lacombe, E. Post, C. Reker-Smit, L. Beljaars, and K. Poelstra Enhanced effectivity of an ALK5-inhibitor after cell-specific delivery to hepatic stellate cells in mice with liver injury PLoS One 8 2013 e56442
94. J. Prakash, L. Beljaars, A.K. Harapanahalli, M. Zeinstra-Smith, A. de Jager-Krikken, M. Hessing, H. Steen, and K. Poelstra Tumor-targeted intracellular delivery of anticancer drugs through the mannose-6-phosphate/ insulin-like growth factor II receptor Int. J. Cancer 126 2010 1966 1981
95. Z. Ye, K. Cheng, R.V. Guntaka, and R.I. Mahato Targeted delivery of a triplex-forming oligonucleotide to hepatic stellate cells Biochemistry 44 2005 4466 4476 (Pubitemid 40403989)
96. Z. Ye, K. Cheng, R.V. Guntaka, and R.I. Mahato Receptor-mediated hepatic uptake of M6P-BSA-conjugated triplex-forming oligonucleotides in rats Bioconjug. Chem. 17 2006 823 830 (Pubitemid 43794394)
97. L. Zhu, and R.I. Mahato Targeted delivery of siRNA to hepatocytes and hepatic stellate cells by bioconjugation Bioconjug. Chem. 21 2010 2119 2127
98. Y. Barenholz Doxil®-the first FDA-approved nano-drug: lessons learned J. Control. Release 160 2012 117 134
99. T.M. Allen, and P.R. Cullis Liposomal drug delivery systems: from concept to clinical applications Adv. Drug Deliv. Rev. 65 2013 36 48
100. H. Ishihara Current status and prospects of polyethyleneglycol-modified medicines Biol. Pharm. Bull. 36 2013 883 888
101. T.M. Allen, C.B. Hansen, and D.E.L. de Menezes Pharmacokinetics of long-circulating liposomes Adv. Drug Deliv. Rev. 16 1995 267 284
102. J. Dave, and H.M. Patel Differentiation in hepatic and splenic phagocytic activity during reticuloendothelial blockade with cholesterol-free and cholesterol-rich liposomes Biochim. Biophys. Acta 888 1986 184 190 (Pubitemid 16026203)
103. S.C. Semple, A. Chonn, and P.R. Cullis Influence of cholesterol on the association of plasma proteins with liposomes Biochemistry 35 1996 2521 2525 (Pubitemid 26098761)
104. R.L. Juliano, and D. Stamp The effect of particle size and charge on the clearance rates of liposomes and liposome encapsulated drugs Biochem. Biophys. Res. Commun. 63 1975 651 658
105. T.M. Allen, P. Williamson, and R.A. Schlegel Phosphatidylserine as a determinant of reticuloendothelial recognition of liposome models of the erythrocyte surface Proc. Natl. Acad. Sci. U. S. A. 85 1988 8067 8071
106. A. Gabizon, and D. Papahadjopoulos The role of surface charge and hydrophilic groups on liposome clearance in vivo Biochim. Biophys. Acta 1103 1992 94 100
107. F. Liu, H. Qi, L. Huang, and D. Liu Factors controlling the efficiency of cationic lipid-mediated transfection in vivo via intravenous administration Gene Ther. 4 1997 517 523 (Pubitemid 27352948)
108. S. Li, and L. Huang In vivo gene transfer via intravenous administration of cationic lipid-protamine-DNA (LPD) complexes Gene Ther. 4 1997 891 900 (Pubitemid 27437714)
109. P. Charoensit, S. Kawakami, Y. Higuchi, F. Yamashita, and M. Hashida Enhanced growth inhibition of metastatic lung tumors by intravenous injection of ATRA-cationic liposome/IL-12 pDNA complexes in mice Cancer Gene Ther. 17 2010 512 522
110. W. Yeeprae, S. Kawakami, S. Suzuki, F. Yamashita, and M. Hashida Physicochemical and pharmacokinetic characteristics of cationic liposomes Pharmazie 61 2006 102 105 (Pubitemid 43293890)
111. T.M. Allen, and A. Chonn Large unilamellar liposomes with low uptake into the reticuloendothelial system FEBS Lett. 223 1987 42 46
112. A.L. Klibanov, K. Maruyama, V.P. Torchilin, and L. Huang Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes FEBS Lett. 268 1990 235 237 (Pubitemid 20233874)
113. T.M. Allen, C. Hansen, F. Martin, C. Redemann, and A. Yau-Young Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo Biochim. Biophys. Acta 1066 1991 29 36
114. M.C. Woodle, K.K. Matthay, M.S. Newman, J.E. Hidayat, L.R. Collins, C. Redemann, F.J. Martin, and D. Papahadjopoulos Versatility in lipid compositions showing prolonged circulation with sterically stabilized liposomes Biochim. Biophys. Acta 1105 1992 193 200
115. K. Maruyama, T. Yuda, A. Okamoto, S. Kojima, A. Suginaka, and M. Iwatsuru Prolonged circulation time in vivo of large unilamellar liposomes composed of distearoyl phosphatidylcholine and cholesterol containing amphipathic poly(ethylene glycol) Biochim. Biophys. Acta 1128 1992 44 49
116. H. Maeda Macromolecular therapeutics in cancer treatment: the EPR effect and beyond J. Control. Release 164 2012 138 144
117. A. Gabizon, R. Catane, B. Uziely, B. Kaufman, T. Safra, R. Cohen, F. Martin, A. Huang, and Y. Barenholz Prolonged circulation time and enhanced accumulation in malignant exudates of doxorubicin encapsulated in polyethylene-glycol coated liposomes Cancer Res. 54 1994 987 992 (Pubitemid 24085451)
118. E.T. Dams, P. Laverman, W.J. Oyen, G. Storm, G.L. Scherphof, J.W. van Der Meer, F.H. Corstens, and O.C. Boerman Accelerated blood clearance and altered biodistribution of repeated injections of sterically stabilized liposomes J. Pharmacol. Exp. Ther. 292 2000 1071 1079 (Pubitemid 30136603)
119. P. Laverman, M.G. Carstens, O.C. Boerman, E.T. Dams, W.J. Oyen, N. van Rooijen, F.H. Corstens, and G. Storm Factors affecting the accelerated blood clearance of polyethylene glycol-liposomes upon repeated injection J. Pharmacol. Exp. Ther. 298 2001 607 612 (Pubitemid 32673411)
120. N. Van Rooijen, and A. Sanders Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications J. Immunol. Methods 174 1994 83 93
121. T. Ishida, R. Maeda, M. Ichihara, K. Irimura, and H. Kiwada Accelerated clearance of PEGylated liposomes in rats after repeated injections J. Control. Release 88 2003 35 42 (Pubitemid 36173950)
122. T. Ishida, K. Masuda, T. Ichikawa, M. Ichihara, K. Irimura, and H. Kiwada Accelerated clearance of a second injection of PEGylated liposomes in mice Int. J. Pharm. 255 2003 167 174 (Pubitemid 36369600)
123. T. Ishida, T. Ichikawa, M. Ichihara, Y. Sadzuka, and H. Kiwada Effect of the physicochemical properties of initially injected liposomes on the clearance of subsequently injected PEGylated liposomes in mice J. Control. Release 95 2004 403 412 (Pubitemid 38340491)
124. T. Ishida, M. Ichihara, X. Wang, K. Yamamoto, J. Kimura, E. Majima, and H. Kiwada Injection of PEGylated liposomes in rats elicits PEG-specific IgM, which is responsible for rapid elimination of a second dose of PEGylated liposomes J. Control. Release 112 2006 15 25
125. T. Ishida, and H. Kiwada Anti-polyethyleneglycol antibody response to PEGylated substances Biol. Pharm. Bull. 36 2013 889 891
126. T. Ishida, K. Atobe, X. Wang, and H. Kiwada Accelerated blood clearance of PEGylated liposomes upon repeated injections: effect of doxorubicin- encapsulation and high-dose first injection J. Control. Release 115 2006 251 258 (Pubitemid 44634849)
127. E. Regoeczi, M.T. Debanne, M.C. Hatton, and A. Koj Elimination of asialofetuin and asialoorosomucoid by the intact rat. Quantitative aspects of the hepatic clearance mechanism Biochim. Biophys. Acta 541 1978 372 384 (Pubitemid 8370389)
128. S. Tsuchiya, Y. Aramaki, T. Hara, K. Hosoi, and A. Okada Preparation and disposition of asialofetuin-labelled liposome Biopharm. Drug Dispos. 7 1986 549 558 (Pubitemid 17033693)
129. T. Hara, Y. Aramaki, S. Tsuchiya, K. Hosoi, and A. Okada Specific incorporation of asialofetuin-labeled liposomes into hepatocytes through the action of galactose-binding protein Biopharm. Drug Dispos. 8 1987 327 339 (Pubitemid 17114981)
130. J. Wu, P. Liu, J.L. Zhu, S. Maddukuri, and M.A. Zern Increased liver uptake of liposomes and improved targeting efficacy by labeling with asialofetuin in rodents Hepatology 27 1998 772 778 (Pubitemid 28103554)
131. H.H. Spanjer, T.J. van Berkel, G.L. Scherphof, and H.J. Kempen The effect of a water-soluble tris-galactoside terminated cholesterol derivative on the in vivo fate of small unilamellar vesicles in rats Biochim. Biophys. Acta 816 1985 396 402 (Pubitemid 15047337)
132. L.A. Sliedregt, P.C. Rensen, E.T. Rump, P.J. van Santbrink, M.K. Bijsterbosch, A.R. Valentijn, G.A. van der Marel, J.H. van Boom, T.J. van Berkel, and E.A. Biessen Design and synthesis of novel amphiphilic dendritic galactosides for selective targeting of liposomes to the hepatic asialoglycoprotein receptor J. Med. Chem. 42 1999 609 618 (Pubitemid 29110777)
133. A. Sasaki, N. Murahashi, H. Yamada, and A. Morikawa Syntheses of novel galactosyl ligands for liposomes and their accumulation in the rat liver Biol. Pharm. Bull. 17 1994 680 685 (Pubitemid 24186117)
134. A. Sasaki, N. Murahashi, H. Yamada, and A. Morikawa Syntheses of novel galactosyl ligands for liposomes and the influence of the spacer on accumulation in the rat liver Biol. Pharm. Bull. 18 1995 740 746
135. N. Murahashi, H. Ishihara, A. Sasaki, M. Sakagami, and H. Hamana Hepatic accumulation of glutamic acid branched neogalactosyllipid modified liposomes Biol. Pharm. Bull. 20 1997 259 266 (Pubitemid 27148975)
136. M. Garg, T. Dutta, and N.K. Jain Reduced hepatic toxicity, enhanced cellular uptake and altered pharmacokinetics of stavudine loaded galactosylated liposomes Eur. J. Pharm. Biopharm. 67 2007 76 85 (Pubitemid 46991319)
137. S. Kawakami, F. Yamashita, M. Nishikawa, Y. Takakura, and M. Hashida Asialoglycoprotein receptor-mediated gene transfer using novel galactosylated cationic liposomes Biochem. Biophys. Res. Commun. 252 1998 78 83 (Pubitemid 28534630)
138. S. Kawakami, C. Munakata, S. Fumoto, F. Yamashita, and M. Hashida Novel galactosylated liposomes for hepatocyte-selective targeting of lipophilic drugs J. Pharm. Sci. 90 2001 105 113 (Pubitemid 32158038)
139. C. Managit, S. Kawakami, F. Yamashita, and M. Hashida Effect of galactose density on asialoglycoprotein receptor-mediated uptake of galactosylated liposomes J. Pharm. Sci. 94 2005 2266 2275 (Pubitemid 41665286)
140. Y. Hattori, S. Kawakami, F. Yamashita, and M. Hashida Controlled biodistribution of galactosylated liposomes and incorporated probucol in hepatocyte-selective drug targeting J. Control. Release 69 2000 369 377
141. A. Murao, M. Nishikawa, C. Managit, J. Wong, S. Kawakami, F. Yamashita, and M. Hashida Targeting efficiency of galactosylated liposomes to hepatocytes
142. C. Managit, S. Kawakami, M. Nishikawa, F. Yamashita, and M. Hashida Targeted and sustained drug delivery using PEGylated galactosylated liposomes Int. J. Pharm. 266 2003 77 84 (Pubitemid 37249309)
143. S. Wang, H. Xu, J. Xu, Y. Zhang, Y. Liu, Y.H. Deng, and D. Chen Sustained liver targeting and improved antiproliferative effect of doxorubicin liposomes modified with galactosylated lipid and PEG-lipid AAPS PharmSciTech 11 2010 870 877
144. Y. Xiao, H. Zhang, Z. Zhang, M. Yan, M. Lei, K. Zeng, and C. Zhao Synthesis of novel tetravalent galactosylated DTPA-DSPE and study on hepatocyte-targeting efficiency in vitro and in vivo Int. J. Nanomedicine 8 2013 3033 3050
145. 1 to hepatocytes using galactosylated liposomes J. Drug Target. 8 2000 137 142 (Pubitemid 30609581)
146. C. Zhao, Q. Feng, Z. Dou, W. Yuan, C. Sui, X. Zhang, G. Xia, H. Sun, and J. Ma Local targeted therapy of liver metastasis from colon cancer by galactosylated liposome encapsulated with doxorubicin PLoS One 8 2013 e73860
147. C. Díaz, E. Vargas, and O. Gätjens-Boniche Cytotoxic effect induced by retinoic acid loaded into galactosyl-sphingosine containing liposomes on human hepatoma cell lines Int. J. Pharm. 325 2006 108 115 (Pubitemid 44573704)
148. T. Terada, M. Iwai, S. Kawakami, F. Yamashita, and M. Hashida Novel PEG-matrix metalloproteinase-2 cleavable peptide-lipid containing galactosylated liposomes for hepatocellular carcinoma-selective targeting J. Control. Release 111 2006 333 342
149. M. Garg, B.R. Garg, S. Jain, P. Mishra, R.K. Sharma, A.K. Mishra, T. Dutta, and N.K. Jain Radiolabeling, pharmacoscintigraphic evaluation and antiretroviral efficacy of stavudine loaded 99mTc labeled galactosylated liposomes Eur. J. Pharm. Sci. 33 2008 271 281
150. A.F. Chambers, and L.M. Matrisian Changing views of the role of matrix metalloproteinases in metastasis J. Natl. Cancer Inst. 89 1997 1260 1270 (Pubitemid 27371946)
151. S. Curran, and G.I. Murray Matrix metalloproteinases in tumour invasion and metastasis J. Pathol. 189 1999 300 308 (Pubitemid 29489213)
152. Y. Murawaki, S. Yamada, Y. Ikuta, and H. Kawasaki Clinical usefulness of serum matrix metalloproteinase-2 concentration in patients with chronic viral liver disease J. Hepatol. 30 1999 1090 1098 (Pubitemid 29278754)
153. H. Hatakeyama, H. Akita, K. Kogure, M. Oishi, Y. Nagasaki, Y. Kihira, M. Ueno, H. Kobayashi, H. Kikuchi, and H. Harashima Development of a novel systemic gene delivery system for cancer therapy with a tumor-specific cleavable PEG-lipid Gene Ther. 14 2007 68 77 (Pubitemid 44942867)
154. Y. Sakurai, H. Hatakeyama, H. Akita, M. Oishi, Y. Nagasaki, S. Futaki, and H. Harashima Efficient short interference RNA delivery to tumor cells using a combination of octaarginine, GALA and tumor-specific, cleavable polyethylene glycol system Biol. Pharm. Bull. 32 2009 928 932
155. H. Hatakeyama, H. Akita, and H. Harashima The polyethyleneglycol dilemma: advantage and disadvantage of PEGylation of liposomes for systemic genes and nucleic acids delivery to tumors Biol. Pharm. Bull. 36 2013 892 899
156. S. Kawakami, S. Fumoto, M. Nishikawa, F. Yamashita, and M. Hashida In vivo gene delivery to the liver using novel galactosylated cationic liposomes Pharm. Res. 17 2000 306 313 (Pubitemid 30225134)
157. S. Fumoto, F. Nakadori, S. Kawakami, M. Nishikawa, F. Yamashita, and M. Hashida Analysis of hepatic disposition of galactosylated cationic liposome/plasmid DNA complexes in perfused rat liver Pharm. Res. 20 2003 1452 1459 (Pubitemid 37164054)
158. E. Letrou-Bonneval, R. Chèvre, O. Lambert, P. Costet, C. André, C. Tellier, and B. Pitard Galactosylated multimodular lipoplexes for specific gene transfer into primary hepatocytes J. Gene Med. 10 2008 1198 1209
159. S. Kawakami, Y. Ito, S. Fumoto, F. Yamashita, and M. Hashida Enhanced gene expression in lung by a stabilized lipoplex using sodium chloride for complex formation J. Gene Med. 7 2005 1526 1533 (Pubitemid 43025513)
160. S. Fumoto, S. Kawakami, Y. Ito, K. Shigeta, F. Yamashita, and M. Hashida Enhanced hepatocyte-selective in vivo gene expression by stabilized galactosylated liposome/plasmid DNA complex using sodium chloride for complex formation Mol. Ther. 10 2004 719 729 (Pubitemid 39272861)
161. S. Fumoto, S. Kawakami, K. Shigeta, Y. Higuchi, F. Yamashita, and M. Hashida Interaction with blood components plays a crucial role in asialoglycoprotein receptor-mediated in vivo gene transfer by galactosylated lipoplex J. Pharmacol. Exp. Ther. 315 2005 484 493 (Pubitemid 41500711)
162. E. Perouzel, M.R. Jorgensen, M. Keller, and A.D. Miller Synthesis and formulation of neoglycolipids for the functionalization of liposomes and lipoplexes Bioconjug. Chem. 14 2003 884 898 (Pubitemid 37152947)
163. J.S. Choi, J.A. MacKay, and F.C. Szoka Jr. Low-pH-sensitive PEG-stabilized plasmid-lipid nanoparticles: preparation and characterization Bioconjug. Chem. 14 2003 420 429 (Pubitemid 36348666)
164. J.H. Felgner, R. Kumar, C.N. Sridhar, C.J. Wheeler, Y.J. Tsai, R. Border, P. Ramsey, M. Martin, and P.L. Felgner Enhanced gene delivery and mechanism studies with a novel series of cationic lipid formulations J. Biol. Chem. 269 1994 2550 2561 (Pubitemid 24235749)
165. Y. Saito, S. Kawakami, Y. Yabe, F. Yamashita, and M. Hashida Intracellular trafficking is the important process that determines the optimal charge ratio on transfection by galactosylated lipoplex in HepG2 cells Biol. Pharm. Bull. 29 2006 1986 1990 (Pubitemid 44338434)
166. K. Shigeta, S. Kawakami, Y. Higuchi, T. Okuda, H. Yagi, F. Yamashita, and M. Hashida Novel histidine-conjugated galactosylated cationic liposomes for efficient hepatocyte-selective gene transfer in human hepatoma HepG2 cells J. Control. Release 118 2007 262 270 (Pubitemid 46329736)
167. K.L. Chang, Y. Higuchi, S. Kawakami, F. Yamashita, and M. Hashida Development of lysine-histidine dendron modified chitosan for improving transfection efficiency in HEK293 cells J. Control. Release 156 2011 195 202
168. Y. Hu, M.T. Haynes, Y. Wang, F. Liu, and L. Huang A highly efficient synthetic vector: nonhydrodynamic delivery of DNA to hepatocyte nuclei in vivo ACS Nano 7 2013 5376 5384
169. S. Kawakami, and M. Hashida Targeted delivery systems of small interfering RNA by systemic administration Drug Metab. Pharmacokinet. 22 2007 142 151
170. Y. Higuchi, S. Kawakami, and M. Hashida Strategies for in vivo delivery of siRNAs: recent progress BioDrugs 24 2010 195 205
171. A. Sato, M. Takagi, A. Shimamoto, S. Kawakami, and M. Hashida Small interfering RNA delivery to the liver by intravenous administration of galactosylated cationic liposomes in mice Biomaterials 28 2007 1434 1442 (Pubitemid 44959042)
172. S. Sonoke, T. Ueda, K. Fujiwara, K. Kuwabara, and J. Yano Galactose-modified cationic liposomes as a liver-targeting delivery system for small interfering RNA Biol. Pharm. Bull. 34 2011 1338 1342
173. N. Jiang, X. Zhang, X. Zheng, D. Chen, Y. Zhang, L.K. Siu, H.B. Xin, R. Li, H. Zhao, N. Riordan, T.E. Ichim, D. Quan, A.M. Jevnikar, G. Chen, and W. Min Targeted gene silencing of TLR4 using liposomal nanoparticles for preventing liver ischemia reperfusion injury Am. J. Transplant. 11 2011 1835 1844
174. N. Jiang, X. Zhang, X. Zheng, D. Chen, K. Siu, H. Wang, T.E. Ichim, D. Quan, V. McAlister, G. Chen, and W.P. Min A novel in vivo siRNA delivery system specifically targeting liver cells for protection of ConA-induced fulminant hepatitis PLoS One 7 2012 e44138
175. G. Barratt, J.P. Tenu, A. Yapo, and J.F. Petit Preparation and characterisation of liposomes containing mannosylated phospholipids capable of targetting drugs to macrophages Biochim. Biophys. Acta 862 1986 153 164 (Pubitemid 17181078)
176. M. Moonis, I. Ahmad, and B.K. Bachhawat Mannosylated liposomes as carriers for hamycin in the treatment of experimental aspergillosis in Balb/C mice J. Drug Target. 1 1993 147 155
177. C.D. Muller, and F. Schuber Neo-mannosylated liposomes: synthesis and interaction with mouse Kupffer cells and resident peritoneal macrophages Biochim. Biophys. Acta 986 1989 97 105 (Pubitemid 19281628)
178. + cytotoxic T lymphocytes FEBS Lett. 441 1998 353 356 (Pubitemid 29065313)
179. S. Kawakami, J. Wong, A. Sato, Y. Hattori, F. Yamashita, and M. Hashida Biodistribution characteristics of mannosylated, fucosylated, and galactosylated liposomes in mice Biochim. Biophys. Acta 1524 2000 258 265
180. A. Düffels, L.G. Green, S.V. Ley, and A.D. Miller Synthesis of high-mannose type neoglycolipids: active targeting of liposomes to macrophages in gene therapy Chemistry 6 2000 1416 1430
181. S. Espuelas, P. Haller, F. Schuber, and B. Frisch Synthesis of an amphiphilic tetraantennary mannosyl conjugate and incorporation into liposome carriers Bioorg. Med. Chem. Lett. 13 2003 2557 2560 (Pubitemid 36830772)
182. A. Engel, S.K. Chatterjee, A. Al-arifi, D. Riemann, J. Langner, and P. Nuhn Influence of spacer length on interaction of mannosylated liposomes with human phagocytic cells Pharm. Res. 20 2003 51 57 (Pubitemid 36152917)
183. K.L. White, T. Rades, R.H. Furneaux, P.C. Tyler, and S. Hook Mannosylated liposomes as antigen delivery vehicles for targeting to dendritic cells J. Pharm. Pharmacol. 58 2006 729 737 (Pubitemid 43836160)
184. M. Garg, A. Asthana, H.B. Agashe, G.P. Agrawal, and N.K. Jain Stavudine-loaded mannosylated liposomes: in-vitro anti-HIV-I activity, tissue distribution and pharmacokinetics J. Pharm. Pharmacol. 58 2006 605 616
185. S. Chono, T. Tanino, T. Seki, and K. Morimoto Uptake characteristics of liposomes by rat alveolar macrophages: influence of particle size and surface mannose modification J. Pharm. Pharmacol. 59 2007 75 80 (Pubitemid 46133045)
186. S. Espuelas, C. Thumann, B. Heurtault, F. Schuber, and B. Frisch Influence of ligand valency on the targeting of immature human dendritic cells by mannosylated liposomes Bioconjug. Chem. 19 2008 2385 2393
187. S. Ghosh, N. Das, A.K. Mandal, S.R. Dungdung, and S. Sarkar Mannosylated liposomal cytidine 5′ diphosphocholine prevent age related global moderate cerebral ischemia reperfusion induced mitochondrial cytochrome c release in aged rat brain Neuroscience 171 2010 1287 1299
188. F. Perche, T. Benvegnu, M. Berchel, L. Lebegue, C. Pichon, P.A. Jaffrès, and P. Midoux Enhancement of dendritic cells transfection in vivo and of vaccination against B16F10 melanoma with mannosylated histidylated lipopolyplexes loaded with tumor antigen messenger RNA Nanomedicine 7 2011 445 453
189. A. Rathore, A. Jain, A. Gulbake, S. Shilpi, P. Khare, A. Jain, and S.K. Jain Mannosylated liposomes bearing Amphotericin B for effective management of visceral Leishmaniasis J. Liposome Res. 21 2011 333 340
190. F. Kong, F. Zhou, L. Ge, X. Liu, and Y. Wang Mannosylated liposomes for targeted gene delivery Int. J. Nanomedicine 7 2012 1079 1089
191. 64Cu liposomes Biomaterials 33 2012 7785 7793
192. S. Kawakami, A. Sato, M. Nishikawa, F. Yamashita, and M. Hashida Mannose receptor-mediated gene transfer into macrophages using novel mannosylated cationic liposomes Gene Ther. 7 2000 292 299 (Pubitemid 30119732)
193. P. Opanasopit, M. Sakai, M. Nishikawa, S. Kawakami, F. Yamashita, and M. Hashida Inhibition of liver metastasis by targeting of immunomodulators using mannosylated liposome carriers J. Control. Release 80 2002 283 294 (Pubitemid 34273766)
194. Y. Hattori, S. Suzuki, S. Kawakami, F. Yamashita, and M. Hashida The role of dioleoylphosphatidylethanolamine (DOPE) in targeted gene delivery with mannosylated cationic liposomes via intravenous route J. Control. Release 108 2005 484 495 (Pubitemid 41608679)
195. Y. Higuchi, S. Kawakami, M. Oka, Y. Yabe, F. Yamashita, and M. Hashida Intravenous administration of mannosylated cationic liposome/NFkappaB decoy complexes effectively prevent LPS-induced cytokine production in a murine liver failure model FEBS Lett. 580 2006 3706 3714 (Pubitemid 43902808)
196. Y. Kuramoto, S. Kawakami, S. Zhou, K. Fukuda, F. Yamashita, and M. Hashida Mannosylated cationic liposomes/CpG DNA complex for the treatment of hepatic metastasis after intravenous administration in mice J. Pharm. Sci. 98 2009 1193 1197
197. H. Huang, F. Sakurai, Y. Higuchi, S. Kawakami, M. Hashida, K. Kawabata, and H. Mizuguchi Suppressive effects of sugar-modified cationic liposome/NF-κB decoy complexes on adenovirus vector-induced innate immune responses J. Control. Release 133 2009 139 145
198. Y. Hattori, S. Kawakami, K. Nakamura, F. Yamashita, and M. Hashida Efficient gene transfer into macrophages and dendritic cells by in vivo gene delivery with mannosylated lipoplex via the intraperitoneal route J. Pharmacol. Exp. Ther. 318 2006 828 834 (Pubitemid 44061257)
199. Y. Hattori, S. Kawakami, Y. Lu, K. Nakamura, F. Yamashita, and M. Hashida Enhanced DNA vaccine potency by mannosylated lipoplex after intraperitoneal administration J. Gene Med. 8 2006 824 834 (Pubitemid 44097138)
200. Y. Lu, S. Kawakami, F. Yamashita, and M. Hashida Development of an antigen-presenting cell-targeted DNA vaccine against melanoma by mannosylated liposomes Biomaterials 28 2007 3255 3262 (Pubitemid 46654220)
201. Y. Kuramoto, S. Kawakami, S. Zhou, K. Fukuda, F. Yamashita, and M. Hashida Use of mannosylated cationic liposomes/ immunostimulatory CpG DNA complex for effective inhibition of peritoneal dissemination in mice J. Gene Med. 10 2008 392 399 (Pubitemid 351517095)
202. W. Wijagkanalan, Y. Higuchi, S. Kawakami, M. Teshima, H. Sasaki, and M. Hashida Enhanced anti-inflammation of inhaled dexamethasone palmitate using mannosylated liposomes in an endotoxin-induced lung inflammation model Mol. Pharmacol. 74 2008 1183 1192
203. W. Wijagkanalan, S. Kawakami, Y. Higuchi, F. Yamashita, and M. Hashida Intratracheally instilled mannosylated cationic liposome/NFκB decoy complexes for effective prevention of LPS-induced lung inflammation J. Control. Release 149 2011 42 50
204. Y. Shimizu, H. Takagi, T. Nakayama, K. Yamakami, T. Tadakuma, N. Yokoyama, and N. Kojima Intraperitoneal immunization with oligomannose-coated liposome-entrapped soluble leishmanial antigen induces antigen-specific T-helper type immune response in BALB/c mice through uptake by peritoneal macrophages Parasite Immunol. 29 2007 229 239 (Pubitemid 46596114)
205. Y. Ikehara, N. Shiuchi, S. Kabata-Ikehara, H. Nakanishi, N. Yokoyama, H. Takagi, T. Nagata, Y. Koide, K. Kuzushima, T. Takahashi, K. Tsujimura, and N. Kojima Effective induction of anti-tumor immune responses with oligomannose-coated liposome targeting to intraperitoneal phagocytic cells Cancer Lett. 260 2008 137 145
206. W. Yeeprae, S. Kawakami, F. Yamashita, and M. Hashida Effect of mannose density on mannose receptor-mediated cellular uptake of mannosylated O/W emulsions by macrophages J. Control. Release 114 2006 193 201 (Pubitemid 44291840)
207. H.S. Jeong, C.M. Lee, S.J. Cheong, E.M. Kim, H. Hwang, K.S. Na, S.T. Lim, M.H. Sohn, and H.J. Jeong The effect of mannosylation of liposome-encapsulated indocyanine green on imaging of sentinel lymph node J. Liposome Res. 23 2013 291 297
208. S. Kawakami, Y. Hattori, Y. Lu, Y. Higuchi, F. Yamashita, and M. Hashida Effect of cationic charge on receptor-mediated transfection using mannosylated cationic liposome/plasmid DNA complexes following the intravenous administration in mice Pharmazie 59 2004 405 408 (Pubitemid 38720351)
209. P. Li, S. Chen, Y. Jiang, J. Jiang, Z. Zhang, and X. Sun Dendritic cell targeted liposomes-protamine-DNA complexes mediated by synthetic mannosylated cholesterol as a potential carrier for DNA vaccine Nanotechnology 24 2013 295101
210. K. Nakamura, Y. Kuramoto, H. Mukai, S. Kawakami, Y. Higuchi, and M. Hashida Enhanced gene transfection in macrophages by histidine-conjugated mannosylated cationic liposomes Biol. Pharm. Bull. 32 2009 1628 1631
211. M. Mizuuchi, Y. Hirohashi, T. Torigoe, T. Kuroda, K. Yasuda, Y. Shimizu, T. Saito, and N. Sato Novel oligomannose liposome-DNA complex DNA vaccination efficiently evokes anti-HPV E6 and E7 CTL responses Exp. Mol. Pathol. 92 2012 185 190
212. R. Suzuki, Y. Oda, N. Utoguchi, and K. Maruyama Progress in the development of ultrasound-mediated gene delivery systems utilizing nano- and microbubbles J. Control. Release 149 2011 36 41
213. R. Suzuki, T. Takizawa, Y. Negishi, K. Hagisawa, K. Tanaka, K. Sawamura, N. Utoguchi, T. Nishioka, and K. Maruyama Gene delivery by combination of novel liposomal bubbles with perfluoropropane and ultrasound J. Control. Release 117 2007 130 136 (Pubitemid 46161862)
214. K. Un, S. Kawakami, R. Suzuki, K. Maruyama, F. Yamashita, and M. Hashida Development of an ultrasound-responsive and mannose-modified gene carrier for DNA vaccine therapy Biomaterials 31 2010 7813 7826
215. K. Un, S. Kawakami, R. Suzuki, K. Maruyama, F. Yamashita, and M. Hashida Suppression of melanoma growth and metastasis by DNA vaccination using an ultrasound-responsive and mannose-modified gene carrier Mol. Pharm. 8 2011 543 554
216. K. Un, S. Kawakami, M. Yoshida, Y. Higuchi, R. Suzuki, K. Maruyama, F. Yamashita, and M. Hashida The elucidation of gene transferring mechanism by ultrasound-responsive unmodified and mannose-modified lipoplexes Biomaterials 32 2011 4659 4669
217. K. Un, S. Kawakami, Y. Higuchi, R. Suzuki, K. Maruyama, F. Yamashita, and M. Hashida Involvement of activated transcriptional process in efficient gene transfection using unmodified and mannose-modified bubble lipoplexes with ultrasound exposure J. Control. Release 156 2011 355 363
218. K. Un, S. Kawakami, M. Yoshida, Y. Higuchi, R. Suzuki, K. Maruyama, F. Yamashita, and M. Hashida Efficient suppression of murine intracellular adhesion molecule-1 using ultrasound-responsive and mannose-modified lipoplexes inhibits acute hepatic inflammation Hepatology 56 2012 259 269
219. Y. Kono, S. Kawakami, Y. Higuchi, K. Maruyama, F. Yamashita, and M. Hashida Tumour-associated macrophage targeted NF-κB decoy transfection with mannose-modified bubble lipoplexes inhibits tumour growth in tumour bearing mice J. Drug Target. 22 2014 439 449
220. T. Kurosaki, S. Kawakami, Y. Higuchi, R. Suzuki, K. Maruyama, H. Sasaki, F. Yamashita, and M. Hashida Development of anionic bubble lipopolyplexes for efficient and safe gene transfection with ultrasound exposure in mice J. Control. Release 176 2014 24 34
221. A.L. Klibanov, J.J. Rychak, W.C. Yang, S. Alikhani, B. Li, S. Acton, J.R. Lindner, K. Ley, and S. Kaul Targeted ultrasound contrast agent for molecular imaging of inflammation in high-shear flow Contrast Media Mol. Imaging 1 2006 259 266
222. E.A. Ferrante, J.E. Pickard, J. Rychak, A. Klibanov, and K. Ley Dual targeting improves microbubble contrast agent adhesion to VCAM-1 and P-selectin under flow J. Control. Release 140 2009 100 107
223. R.S. Haltiwanger, M.A. Lehrman, A.E. Eckhardt, and R.L. Hill The distribution and localization of the fucose-binding lectin in rat tissues and the identification of a high affinity form of the mannose/N-acetylglucosamine- binding lectin in rat liver J. Biol. Chem. 261 1986 7433 7439 (Pubitemid 17224748)
224. Y. Higuchi, M. Nishikawa, S. Kawakami, F. Yamashita, and M. Hashida Uptake characteristics of mannosylated and fucosylated bovine serum albumin in primary cultured rat sinusoidal endothelial cells and Kupffer cells Int. J. Pharm. 287 2004 147 154 (Pubitemid 39487252)
225. Y. Higuchi, S. Kawakami, F. Yamashita, and M. Hashida The potential role of fucosylated cationic liposome/NFκB decoy complexes in the treatment of cytokine-related liver disease Biomaterials 28 2007 532 539 (Pubitemid 44602230)
226. M. Yoshida, R. Takimoto, K. Murase, Y. Sato, M. Hirakawa, F. Tamura, T. Sato, S. Iyama, T. Osuga, K. Miyanishi, K. Takada, T. Hayashi, M. Kobune, and J. Kato Targeting anticancer drug delivery to pancreatic cancer cells using a fucose-bound nanoparticle approach PLoS One 7 2012 e39545
227. C.H. Campbell, A.L. Miller, and L.H. Rome Incorporation of mannose 6-phosphate receptors into liposomes. Receptor topography and binding of α-mannosidase Biochem. J. 214 1983 413 419 (Pubitemid 13035522)
228. J.E. Adrian, K. Poelstra, G.L. Scherphof, G. Molema, D.K. Meijer, C. Reker-Smit, H.W. Morselt, and J.A. Kamps Interaction of targeted liposomes with primary cultured hepatic stellate cells: Involvement of multiple receptor systems J. Hepatol. 44 2006 560 567 (Pubitemid 43227881)
229. J.E. Adrian, K. Poelstra, G.L. Scherphof, D.K. Meijer, A.M. van Loenen-Weemaes, C. Reker-Smit, H.W. Morselt, P. Zwiers, and J.A. Kamps Effects of a new bioactive lipid-based drug carrier on cultured hepatic stellate cells and liver fibrosis in bile duct-ligated rats J. Pharmacol. Exp. Ther. 321 2007 536 543 (Pubitemid 46624503)
230. J.E. Adrian, J.A. Kamps, G.L. Scherphof, D.K. Meijer, A.M. van Loenen-Weemaes, C. Reker-Smit, P. Terpstra, and K. Poelstra A novel lipid-based drug carrier targeted to the non-parenchymal cells, including hepatic stellate cells, in the fibrotic livers of bile duct ligated rats Biochim. Biophys. Acta 1768 2007 1430 1439 (Pubitemid 46795479)
231. J.E. Adrian, J.A. Kamps, K. Poelstra, G.L. Scherphof, D.K. Meijer, and Y. Kaneda Delivery of viral vectors to hepatic stellate cells in fibrotic livers using HVJ envelopes fused with targeted liposomes J. Drug Target. 15 2007 75 82 (Pubitemid 47161334)
232. D. Wakebayashi, N. Nishiyama, Y. Yamasaki, K. Itaka, N. Kanayama, A. Harada, Y. Nagasaki, and K. Kataoka Lactose-conjugated polyion complex micelles incorporating plasmid DNA as a targetable gene vector system: their preparation and gene transfecting efficiency against cultured HepG2 cells J. Control. Release 95 2004 653 664 (Pubitemid 38340512)
233. Y. Wang, C.Y. Hong, and C.Y. Pan Galactose-based amphiphilic block copolymers: synthesis, micellization, and bioapplication Biomacromolecules 14 2013 1444 1451
234. S.S. Yu, C.M. Lau, W.J. Barham, H.M. Onishko, C.E. Nelson, H. Li, C.A. Smith, F.E. Yull, C.L. Duvall, and T.D. Giorgio Macrophage-specific RNA interference targeting via "click", mannosylated polymeric micelles Mol. Pharm. 10 2013 975 987
235. Y. Zou, Y. Song, W. Yang, F. Meng, H. Liu, and Z. Zhong Galactose-installed photo-crosslinked pH-sensitive degradable micelles for active targeting chemotherapy of hepatocellular carcinoma in mice J. Control. Release 2014 (in press)
236. Y. Bae, and K. Kataoka Intelligent polymeric micelles from functional poly(ethylene glycol)-poly(amino acid) block copolymers Adv. Drug Deliv. Rev. 61 2009 768 784
237. K. Itaka, and K. Kataoka Progress and prospects of polyplex nanomicelles for plasmid DNA delivery Curr. Gene Ther. 11 2011 457 465
238. S. Hossain, A. Stanislaus, M.J. Chua, S. Tada, Y. Tagawa, E.H. Chowdhury, and T. Akaike Carbonate apatite-facilitated intracellularly delivered siRNA for efficient knockdown of functional genes J. Control. Release 147 2010 101 108
239. S. Fumoto, and S. Kawakami Combination of nanoparticles with physical stimuli toward cancer therapy Biol. Pharm. Bull. 37 2014 212 216